Author

Dylan J Turner

Quirkos Software - Cited by 1,240 - Qualitative software - qualitative research

Biography

Dr. Dylan J Turner is currently working in Medical Oncology Department at Waikato Hospital. He had published many articles on Oncology. Dylan J Turner's research of interests are Oncology, Geriatric Oncology, Elder care, Gerontology, Aging Science.
Title
Cited by
Year
Temporal sensitivity
AB WatsonHandbook of perception and human performance 1 (6), 1-43, 1986198
551
1986
Primary health and supportive care needs of long-term cancer survivors: a questionnaire survey
SE Harrison, EK Watson, AM Ward, NF Khan, D Turner, E Adams, ...J Clin Oncol 29 (15), 2091-2098, 2011201
195
2011
Partners and close family members of long‐term cancer survivors: health status, psychosocial well‐being and unmet supportive care needs
D Turner, E Adams, M Boulton, S Harrison, N Khan, P Rose, A Ward, ...Psycho‐oncology 22 (1), 12-19, 2013201
99
2013
Implementing intensive insulin therapy: development and audit of the Bath insulin protocol
S Laver, S Preston, D Turner, C McKinstry, A PadkinAnaesthesia and intensive care 32 (3), 311-316, 2004200
83
2004
Obstacles to “race equality” in the English National Health Service: Insights from the healthcare commissioning arena
S Salway, G Mir, D Turner, GTH Ellison, L Carter, K GerrishSocial science & medicine 152, 102-110, 2016201
66
2016
Prospects for progress on health inequalities in England in the post-primary care trust era: professional views on challenges, risks and opportunities
D Turner, S Salway, G Mir, GTH Ellison, J Skinner, L Carter, B BostanBMC Public Health 13 (1), 1-12, 2013201
35
2013
Continuity of care: patients’ and carers’ views and choices in their use of primary care services
R Baker, G Freeman, M Boulton, K Windridge, C Tarrant, J Low, D Turner, ...Report for the national co-ordinating center for NHS Service Delivery and …, 2006200
33
2006
The association of peri‐operative scores, including frailty, with outcomes after unscheduled surgery
DG McGuckin, S Mufti, DJ Turner, C Bond, SR MoonesingheAnaesthesia 73 (7), 819-824, 2018201
29
2018
Selection for ionic-confers silver nanoparticle resistance in Escherichia coli
M Tajkarimi, K Rhinehardt, M Thomas, JA Ewunkem, A Campbell, S Boyd, ...JSM Nanotechnol Nanomed 5 (1), 1047, 2017201
22
2017
Novel method to characterize CYP21A2 in Florida patients with congenital adrenal hyperplasia and commercially available cell lines
CN Greene, SK Cordovado, DP Turner, LM Keong, D Shulman, ...Molecular genetics and metabolism reports 1, 312-323, 2014201
16
2014
Wearable internet of medical things sensor devices, big healthcare data, and artificial intelligence-based diagnostic algorithms in real-time COVID-19 detection and monitoring …
D Turner, A PeraAmerican Journal of Medical Research 8 (2), 2-145, 2021202
13
2021
Race equality and health inequalities: towards more integrated policy and practice
S Salway, L Carter, K Powell, D Turner, G Mir, GTH EllisonRace Equality Briefing Paper, 2014201
12
2014
Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS study
CM Bond, R Holland, DP Alldred, A Arthur, G Barton, A Blyth, ...Trials 21, 1-11, 2020202
12
2020
Hepatotoxicity and antituberculosis therapy: time to revise UK guidance?
NF Walker, M Kliner, D Turner, S Bhagani, I Cropley, S Hopkins, ...Thorax 64 (), 918-918, 2009200
10
2009
Mini Case Study Book Real world examples of using evidence to improve health services for minority ethnic people
D Turner, S Salway, P Chowbey, G MirEvidence and Ethnicity in Commissioning, 2012201
8
2012
High quality healthcare commissioning: Why race equality” must be at its heart
S Salway, D Turner, G Mir, L Carter, J Skinner, B Bostan, K Gerrish, ...Better Health Briefing Paper 27, 1-16, 2013201
5
2013
The Benefit and Tolerability of Adjuvant Chemotherapy in Elderly Stage III Colon Cancer Patients: A 3 Year Retrospective Audit
HS Lin, DJ Turner, A Srivastava, M JamesonOmics Publishing Group, 2016201
4
2016
Diamorphine toxicity
D TurnerAnaesthesia 47 (2), 168-169, 1992199
3
1992
P2. 01-070 circulating biomarkers of frailty are associated with a poor prognosis in patients with advanced non-small cell lung cancer (NSCLC): topic: marker for prognosis
N Wyatt, L Hogarth, D Turner, M Patterson, D Jamieson, F Black, C Hutton, ...Journal of Thoracic Oncology 12 (1), S829-S80, 2017201
3
2017
Evaluation of frailty measures and short-term outcomes after lung transplantation
AC Swaminathan, A McConnell, S Peskoe, MR Bashir, EB Buckley, ...Chest, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=oRVl64sAAAAJ&hl=en&oi=sra

Cited by
Citations 1240
h-index 12
i10-index 16
Open Access Journals